VENTO, Sandro
 Distribuzione geografica
Continente #
EU - Europa 3.283
NA - Nord America 3.270
AS - Asia 2.004
SA - Sud America 497
AF - Africa 35
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 9.099
Nazione #
US - Stati Uniti d'America 3.218
RU - Federazione Russa 1.221
SG - Singapore 891
GB - Regno Unito 827
CN - Cina 587
BR - Brasile 427
DE - Germania 204
SE - Svezia 201
FR - Francia 194
IE - Irlanda 192
FI - Finlandia 187
HK - Hong Kong 178
VN - Vietnam 146
IT - Italia 105
KR - Corea 69
UA - Ucraina 66
AR - Argentina 30
CA - Canada 26
IN - India 22
ZA - Sudafrica 20
TR - Turchia 19
ID - Indonesia 17
MX - Messico 17
NL - Olanda 15
BE - Belgio 14
BD - Bangladesh 13
JP - Giappone 13
CZ - Repubblica Ceca 12
EC - Ecuador 12
ES - Italia 11
IL - Israele 11
PL - Polonia 11
CO - Colombia 7
AU - Australia 6
CL - Cile 6
IQ - Iraq 6
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
AT - Austria 5
EG - Egitto 5
MA - Marocco 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
LT - Lituania 3
NP - Nepal 3
PK - Pakistan 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EU - Europa 2
GR - Grecia 2
LV - Lettonia 2
NO - Norvegia 2
PE - Perù 2
RO - Romania 2
VE - Venezuela 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
CD - Congo 1
CH - Svizzera 1
CR - Costa Rica 1
DK - Danimarca 1
GE - Georgia 1
GN - Guinea 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
HT - Haiti 1
JM - Giamaica 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
MN - Mongolia 1
MY - Malesia 1
NG - Nigeria 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
RE - Reunion 1
SI - Slovenia 1
SV - El Salvador 1
Totale 9.099
Città #
Southend 726
Jacksonville 602
Woodbridge 459
Singapore 420
Chandler 380
Moscow 363
Ann Arbor 198
Dublin 192
Dallas 185
Ashburn 184
Hong Kong 177
Houston 104
Beijing 86
Lawrence 77
Princeton 77
Wilmington 72
Nanjing 63
Los Angeles 54
New York 50
Jinan 46
The Dalles 46
Ho Chi Minh City 45
Shenyang 45
Hanoi 32
São Paulo 32
Buffalo 29
Helsinki 29
Hebei 28
Santa Clara 27
Munich 25
Nanchang 24
Changsha 23
Sindelfingen 23
Milan 22
Turku 22
Redondo Beach 21
Tianjin 21
Jiaxing 19
Denver 17
Frankfurt am Main 17
Ningbo 17
Seattle 17
San Francisco 16
Haikou 15
Brussels 14
London 14
Norwalk 13
Toronto 13
Verona 13
Zhengzhou 13
Bologna 12
Hangzhou 12
Taizhou 12
Boardman 11
Lanzhou 11
Rio de Janeiro 11
Warsaw 11
Atlanta 10
Belo Horizonte 10
Brno 10
Brooklyn 10
Haiphong 10
Johannesburg 10
Taiyuan 10
Tokyo 10
Curitiba 9
Fairfield 9
Porto Alegre 9
Biên Hòa 8
Chennai 8
Chicago 8
Poplar 8
Boston 7
Guangzhou 7
Montreal 7
Orem 7
Phoenix 7
Redmond 7
Stockholm 7
Amsterdam 6
Fuzhou 6
Limeira 6
Redwood City 6
Salvador 6
Santo André 6
Seoul 6
Thái Nguyên 6
Clearwater 5
Columbus 5
Düsseldorf 5
Mexico City 5
Philadelphia 5
Pignone 5
Quito 5
Ribeirão Preto 5
Caxias do Sul 4
Durban 4
Falls Church 4
Ipatinga 4
Jakarta 4
Totale 5.583
Nome #
Aetiology of pneumonia following isolated closed head injury 174
Twice-weekly dapsone for primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1 infection: efficacy, safety and pharmacokinetic data 172
Comparative evaluation of naturally occurring Pneumocystis carinii pneumonia (PCP) and PCP despite primary chemoprophylaxis in patients with AIDS 167
A case of visceral leishmaniasis with protracted incubation in a nonendemic area. 164
Dolutegravir Monotherapy in HIV-Infected Naive Patients With <100,000 Copies/mL HIV RNA Load 164
Is there a role for TNF-alpha in HIV1-associated lipodystrophy? 156
Autoimmune hepatitis type 2 induced by HCV and persisting after viral clearance 154
Dolutegravir 50 mg thrice weekly plus atazanavir 400 mg daily in a long-term virologically suppressed HIV-infected patient 154
Raltegravir/nevirapine dual therapy at reduced doses as 'maintenance' treatment in virally suppressed HIV-infected patients 153
Dolutegravir monotherapy in HIV-1-suppressed patients: A feasible regimen in real life 151
Recreational substance use and tolerance of efavirenz in HIV-1 infected patients 145
Cryptococcal meningitis during cyclosporin treatment in a patient with psoriasis. 145
Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients 144
Clinical picture: Ring calcification in the chest X-ray of a 17-year-old girl: coronary aneurism following Kawasaki disease 140
Does tenofovir increase efavirenz hepatotoxicity? 140
Immunovirological outcome and HIV-1 DNA decay in a small cohort of HIV-1-infected patients deintensificated from Abacavir/Lamivudine/Dolutegravir to Lamivudine plus Dolutegravir 139
Short-Cycle Therapy (5 days on/2 days off) with a lamivudine-dolutegravir two-drug regimen in a cohort of virologically suppressed HIV-infected patients 139
Discontinuation of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy: clinical implications in patients on CD4 T-cell-guided treatment interruption. 138
Can we really identify HIV-1 long-term nonprogressors? 138
Adherence to HAART in HIV. 136
Enanthema as the first clinical manifestation of abacavir hypersensitivity reaction: a case report. 136
Dual therapy with a combination of unboosted atazanavir and lamivudine as maintenance treatment in virologically suppressed HIV-1-infected patients 136
Recovery of long-term natural protection against reactivation of CMV retinitis in AIDS patients responding to highly active antiretroviral therapy. 133
Mortality due to hepatitis C virus-related cirrhosis in patients infected with HIV type 1: a role for alcohol 132
Unusual rapidly growing ulcerative genital mass due to herpes simplex virus in uman immunodeficiency virus-infected woman 131
Autoimmune hepatitis type 1 after measles 129
Early detection of lung cancer in high-risk patients with HIV-1 infection. 128
Hyperacute unilateral gonococcal endophthalmitis in an HIV-infected man without genital infection 127
Hepatitis A virus infection and atherosclerosis 123
Microsporidium species in pulmonary cavitary lesions of AIDS patients infected with Rhodococcus equi 123
Cutaneous abscess due to Eubacterium lentum in injection drug user: a case report and review of the literature 121
Tuberculosis among refugees and displaced people at the Burundi-Rwanda border 120
Diagnosis, management and outcome of clinically-suspected spinal infection 120
Steroid and interferon therapy in liver/kidney microsomal antibody-positive patients with chronic hepatitis C 117
Early detection of lung cancer in high-risk patients with HIV-1 infection. 115
[CD4+ guided interruption HAART in HIV patients] 114
Coxsackie B virus-induced autoimmunity to GAD does not lead to type 1 diabetes. 114
Nosocomial Candidemia in non-neutropenic patients at an Italian tertiary care hospital 113
The PraSight-F rapid dipstick antigen capture assay for monitoring parasite clearance after drug treatment of Plasmodium falciparum malaria 110
Increase in visceral adipose tissue in a woman living with HIV after introduction of integrase strand transfer inhibitor 110
Successful treatment of Castleman’s disease with HAART in two HIV-infected patients 109
Unusual, rapidly growing ulcerative genital mass due to herpes simplex virus in a human immunodeficiency virus-infected woman. 109
mIRTAZAPINE IN AN HIV-INFECTED PATIENT WITH PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 108
Multdrug-resistant tuberculosis 107
M. tuberculosis drug resistance in AIDS 107
Painful neuropathy vasculitis in 2 patients with long-standing human immunodeficiency virus-1 infection. 107
Highly active antiretroviral therapy. 107
Inflammatory pseudotumor of lymph nodes. 107
Efficacy of a reduced dose of darunavir/ritonavir in a cohort of antiretroviral-naive and -experienced HIV-infected patients: a medium-term follow-up 107
Failure of prophylaxis against PCP in patients with HIV infection 106
Initial hospitalization and adherence to highly active antiretroviral therapy. 106
Syphilis in prostitutes from Eastern Europe. 105
Effect of pregnancy on chronic hepatitis C 105
Response of uncomplicated falciparum malaria to oral chloroquine and quinine in Burundi highlands 104
Infection with hepatitis G virus in immunoglobulin recipients 103
Enhancement of hepatitis C virus replication and liver damage in HIV-coinfected patients on antiretroviral combination therapy. 103
Failure of lamivudine therapy for chemotherapy-induced reactivation of hepatitis B. 101
MHC class I molecules and progression to AIDS 101
Prevalence and clinical significance of Ureaplasma urealyticum and Mycoplasma hominis in the lower genital tract of HIV-1-infected women. 100
Fluconazole penetration into the prostatic fluid of patients with AIDS-associated cryptococcal meningitis. 100
Human immunodeficiency virus-associated peripheral neuropathies 99
HIV-1 progression in hepatitis-C- infected drug users 96
Mediastinal lymphadenitis due to cryptococcal infection in HIV-positive patients on highly active antiretroviral therapy. 96
No influence of nevirapine on vitamin D deficiency in HIV-infected patients 95
Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus 94
Epstein-Barr virus as a trigger for autoimmune hepatitis in susceptible individuals 94
Selective drug taking during combination antiretroviral therapy. 94
Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. 94
Highly active antiretroviral therapy. 93
Resolution of autoimmune hepatitis after bone-marrow transplantation 90
Intracranial mass lesions in HIV/AIDS patients from developing countries endemic for neurocysticercosis. 90
No increase in liver decompensation risk with atypical hepatitis C virus antibody pattern. 87
Esophageal cryptococcosis in a patient with AIDS. 86
Isolated Presence of Antibody to Hepatitis B core antigen in injection drug users: do they need to be vaccinated? 84
Short-cycle therapy in {HIV}-infected adults: rilpivirine combination 4 days on/3 days off therapy 83
Nosocomial candidemia in non-neutropenic patients at an Italian tertiary care hospital. 80
Long-term efficacy of dual nucleoside reverse transcriptase inhibitor antiretroviral therapy in HIV-1 infection. 76
Prior Mycobacterium avium complex infection is linked to immunological nonresponsiveness in HIV-infected patients on highly active antiretroviral therapy 72
Totale 9.170
Categoria #
all - tutte 31.857
article - articoli 31.857
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.714


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021318 0 0 0 0 0 85 9 74 46 14 79 11
2021/2022640 47 200 7 27 13 20 12 37 29 29 53 166
2022/20231.179 84 113 121 169 139 275 5 76 150 7 25 15
2023/2024406 27 36 44 44 69 51 5 9 2 9 52 58
2024/20251.385 106 83 26 222 60 24 69 37 254 92 93 319
2025/20262.676 293 264 264 760 1.023 72 0 0 0 0 0 0
Totale 9.170